"WEE"ding Out Resistance to Osimertinib in the "ARID"1A-Mutated Badlands

Affiliations

¹ Thoracic Oncology Research Group, Trinity St James's Cancer Institute, St James's Hospital, Dublin, Ireland.
² Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy; Center of Biotechnology, College of Science and Technology, Temple University, Sbarro Health Research Organization, Philadelphia, Pennsylvania. Electronic address: luciano.mutti@univaq.it.

Editorial

Steven G Gray et al. J Thorac Oncol. 2025 Oct.

. 2025 Oct;20(10):1366-1368.

doi: 10.1016/j.jtho.2025.07.120.

¹ Thoracic Oncology Research Group, Trinity St James's Cancer Institute, St James's Hospital, Dublin, Ireland.
² Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy; Center of Biotechnology, College of Science and Technology, Temple University, Sbarro Health Research Organization, Philadelphia, Pennsylvania. Electronic address: luciano.mutti@univaq.it.

No abstract available

Conflict of interest statement

Disclosure Dr. Gray and Prof. Mutti disclose receiving funding for an investigator-initiated study from Portage Biotech.